11.10.17
The Graphene Flagship, EU’s biggest research initiative into graphene and related materials, will present innovative biomedical technologies at the largest medical trade fair in the world – MEDICA 2017.
With more than 130,000 professional visitors and 5,100 exhibitors expected from Nov. 13-16, 2017 in Dusseldorf, Germany, MEDICA promises to be a wide-reaching platform for the Graphene Flagship to showcase its graphene based novel healthcare solutions.
Graphene and related materials are paving the way for novel biomedical diagnoses and treatments due to their unique properties such as high surface area, electron mobility and surface functionalization.
For instance, the surface area of graphene makes an excellent platform for drug delivery and the conductivity allows for effective biosensors. New research has shown that graphene can also be incorporated with a polymer to make electromechanical sensors and deep brain implants.
“Health, environment and bio-medical applications are part of the roadmap for graphene and related materials,” said Professor Andrea C. Ferrari, science and technology officer of the Graphene Flagship and chair of its management panel said
Graphene Flagship partner Catalan Institute of Nanoscience and Nanotechnology (ICN2) will be displaying two of these demonstrators: a graphene sensor able to detect the electrical activity of the brain providing early detection for neurological events such as epileptic seizures; and a retinal implant which can serve as optical prostheses for people who have lost their sight.
A fully functional robotic hand controlled by a bracelet with graphene sensors will be demoed by Flagship Partner Istituto Italiano di Tecnologia (IIT); IIT is developing this research project with INAIL, the Italian National Institute for Insurance against Accidents at Work.
The Graphene Flagship Partner Guger Technologies (g.tec), headquartered in Austria, will also present a brain computer interface containing graphene electrodes capable of measuring brain activity.
With more than 130,000 professional visitors and 5,100 exhibitors expected from Nov. 13-16, 2017 in Dusseldorf, Germany, MEDICA promises to be a wide-reaching platform for the Graphene Flagship to showcase its graphene based novel healthcare solutions.
Graphene and related materials are paving the way for novel biomedical diagnoses and treatments due to their unique properties such as high surface area, electron mobility and surface functionalization.
For instance, the surface area of graphene makes an excellent platform for drug delivery and the conductivity allows for effective biosensors. New research has shown that graphene can also be incorporated with a polymer to make electromechanical sensors and deep brain implants.
“Health, environment and bio-medical applications are part of the roadmap for graphene and related materials,” said Professor Andrea C. Ferrari, science and technology officer of the Graphene Flagship and chair of its management panel said
Graphene Flagship partner Catalan Institute of Nanoscience and Nanotechnology (ICN2) will be displaying two of these demonstrators: a graphene sensor able to detect the electrical activity of the brain providing early detection for neurological events such as epileptic seizures; and a retinal implant which can serve as optical prostheses for people who have lost their sight.
A fully functional robotic hand controlled by a bracelet with graphene sensors will be demoed by Flagship Partner Istituto Italiano di Tecnologia (IIT); IIT is developing this research project with INAIL, the Italian National Institute for Insurance against Accidents at Work.
The Graphene Flagship Partner Guger Technologies (g.tec), headquartered in Austria, will also present a brain computer interface containing graphene electrodes capable of measuring brain activity.